330
Participants
Start Date
September 30, 2016
Primary Completion Date
August 31, 2021
Study Completion Date
February 28, 2022
Treatment duration of cisplatin based chemotherapy
"* GP regimen: Gemcitabine (1000 mg/m2 D1, D8), Cisplatin (60 mg/m2 D1), every 3 weeks~* GP-S regimen: Gemcitabine (1000 mg/m2 D1, D8), Cisplatin (35 mg/m2 D1,D 2 or D8), every 3 weeks~* MVAC regimen: Methotrexate (30 mg/m2 IV bolus, D1, 15, 22), Vinblastine (3 mg/m2 IV bolus, D2, 15, 22), Doxorubicin (30 mg/m2 IV bolus D2), Cisplatin (70 mg/m2 D2), every 4 weeks~* HD-MVAC with GCSF regimen: Methotrexate (30 mg/m2 IV bolus, D1), Vinblastine (3 mg/m2 IV bolus, D2), Doxorubicin (30 mg/m2 IV bolus D2), Cisplatin (70 mg/m2 D2), G-CSF (240 ug/m2 SC, D4-10), every 2 weeks"
RECRUITING
Kwonoh Park, Yangsan
RECRUITING
Hallym University Medical Center, Hallym University College of Medicine, Anyang
RECRUITING
Fatima Hospital, Daegu
RECRUITING
Keimyeong University Dongsan Medical Center, Daegu
RECRUITING
Chungnam University Hospital, Daejeon
RECRUITING
National Health Insurance Service Ilsan Hospital, Goyang
RECRUITING
Gil Medical Center, Incheon
RECRUITING
Inje University Haeundae Paik Hospital, Pusan
RECRUITING
Kosin University Hospital, Pusan
RECRUITING
Pusan National University Hospital, Pusan National University School of Medicine, Pusan
RECRUITING
Asan Medical Center, Seoul
RECRUITING
Chung Ang University Hospital, Seoul
RECRUITING
Inje University Sanggye Paik Hospital, Seoul
RECRUITING
Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul
RECRUITING
Korea University Anam Hospital, Seoul
RECRUITING
Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul
RECRUITING
VHS medical center, Seoul
RECRUITING
Yonsei Cancer Center, Seoul
RECRUITING
St. Vincent's Hospital, The Catholic University of Korea, Suwon
Lead Sponsor
Korean Cancer Study Group
OTHER
Asan Medical Center
OTHER